Drug profile · INN
durlobactam sodium
XACDURO (COPACKAGED)
durlobactam sodium (XACDURO (COPACKAGED)) is a beta-lactamase inhibitor. Route of administration: intravenous. Current US regulatory status: approved.
Drug details — durlobactam sodium
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
durlobactam sodium (XACDURO (COPACKAGED)) is a beta-lactamase inhibitor. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
Mechanism of action
Beta-lactamase inhibitor
Primary target: Beta-lactamase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is durlobactam sodium?
durlobactam sodium (XACDURO (COPACKAGED)) is a beta-lactamase inhibitor. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for durlobactam sodium?
XACDURO (COPACKAGED) is a marketed brand name for durlobactam sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of durlobactam sodium?
durlobactam sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.